Commonwealth Numbered Regulations Commonwealth Numbered Regulations
Health Insurance (Diagnostic Imaging Services Table) Regulations 2017
1 Schedule 1 (item 61616)
Repeal the item.
2 Schedule 1 (items 61620, 61622 and 61628, column headed "Description")
Omit "Hodgkin's or non-Hodgkin's lymphoma (excluding indolent non-Hodgkin's lymphoma)", substitute "Hodgkin or non-Hodgkin lymphoma".
3 Schedule 1 (item 61632, column headed "Description")
Omit "stem cell transplantation is being considered for Hodgkin's or non-Hodgkin's lymphoma (excluding indolent non-Hodgkin's lymphoma)", substitute "haemopoietic stem cell transplantation is being considered for Hodgkin or non-Hodgkin lymphoma".
Health Insurance (General Medical Services Table) Regulations 2017
4 Schedule 1 (items 11204 and 11205, column headed "Description")
After "standards", insert ", performed by or on behalf of a specialist or consultant physician in the practice of his or her speciality".
5 Schedule 1 (cell at item 20560, column headed "Description")
Repeal the cell, substitute:
| Initiation of the management of anaesthesia for: (a) open procedures on the heart, pericardium or great vessels of the chest; or (b) percutaneous insertion of a valvular prosthesis |
6 Schedule 1 (items 36658, 36660 and 36662)
Repeal the items.
7 Schedule 1 (after item 38275)
Insert:
| 38276 |
Transcatheter occlusion of left atrial appendage, and cardiac catheterisation performed by the same practitioner, for stroke prevention in a patient who has non-valvular atrial fibrillation and a contraindication to life-long oral anticoagulation therapy, and is at increased risk of thromboembolism demonstrated by: (a) a prior stroke (whether of an ischaemic or unknown type), transient ischaemic attack or non-central nervous system systemic embolism; or (b) at least 2 of the following risk factors: (i) an age of 65 years or more; (ii) hypertension; (iii) diabetes mellitus; (iv) heart failure or left ventricular ejection fraction of 35% or less (or both); (v) vascular disease (prior myocardial infarction, peripheral artery disease or aortic plaque) (H) (Anaes.) (Assist.) | 912.30 |
8 Schedule 1 (item 38452, column headed "Description")
Omit "sub-xyphoid", substitute "subxiphoid".
9 Schedule 1 (after item 40700)
Insert:
| 40701 | Vagus nerve stimulation therapy through stimulation of the left vagus nerve, subcutaneous placement of electrical pulse generator, for: (a) management of refractory generalised epilepsy; or (b) treatment of refractory focal epilepsy not suitable for resective epilepsy surgery (H) (Anaes.) (Assist.) | 340.60 |
| 40702 |
Vagus nerve stimulation therapy through stimulation of the left vagus nerve, surgical repositioning or removal of electrical pulse generator inserted for: (a) management of refractory generalised epilepsy; or (b) treatment of refractory focal epilepsy not suitable for resective epilepsy surgery (H) (Anaes.) (Assist.) | 159.40 |
10 Schedule 1 (after item 40703)
Insert:
| 40704 | Vagus nerve stimulation therapy through stimulation of the left vagus nerve, surgical placement of lead, including connection of lead to left vagus nerve and intra-operative test stimulation, for: (a) management of refractory generalised epilepsy; or (b) treatment of refractory focal epilepsy not suitable for resective epilepsy surgery (H) (Anaes.) (Assist.) | 674.15 |
| 40705 | Vagus nerve stimulation therapy through stimulation of the left vagus nerve, surgical repositioning or removal of lead attached to left vagus nerve for: (a) management of refractory generalised epilepsy; or (b) treatment of refractory focal epilepsy not suitable for resective epilepsy surgery (H) (Anaes.) (Assist.) | 605.35 |
11 Schedule 1 (after item 40706)
Insert:
| 40707 | Vagus nerve stimulation therapy through stimulation of the left vagus nerve, electrical analysis and programming of vagus nerve stimulation therapy device using external wand, for: (a) management of refractory generalised epilepsy; or (b) treatment of refractory focal epilepsy not suitable for resective epilepsy surgery |
189.70 |
| 40708 | Vagus nerve stimulation therapy through stimulation of the left vagus nerve, surgical replacement of battery in electrical pulse generator inserted for: (a) management of refractory generalised epilepsy; or (b) treatment of refractory focal epilepsy not suitable for resective epilepsy surgery (H) (Anaes.) (Assist.) | 340.60 |
12 Schedule 1 (items 50950 and 50952)
Repeal the items (including the Subgroup 16 heading), substitute:
| Subgroup 16--Radiofrequency and microwave tissue ablation | ||
| 50950 | Unresectable primary malignant tumour of the liver, destruction of, by percutaneous radiofrequency ablation or percutaneous microwave tissue ablation (including any associated imaging services), other than a service associated with a service to which item 30419 or 50952 applies (Anaes.) | 817.10 |
| 50952 |
Unresectable primary malignant tumour of the liver, destruction of, by open or laparoscopic radiofrequency ablation or open or laparoscopic microwave tissue ablation (including any associated imaging services), if a multi-disciplinary team has assessed that percutaneous radiofrequency ablation or percutaneous microwave tissue ablation cannot be performed or is not practical because of one or more of the following clinical circumstances: (a) percutaneous access cannot be achieved; (b) vital organs or tissues are at risk of damage from the percutaneous radiofrequency ablation or percutaneous microwave tissue ablation procedure; (c) resection of one part of the liver is possible, however there is at least one primary liver tumour in an unresectable portion of the liver that is suitable for radiofrequency ablation or microwave tissue ablation; other than a service associated with a service to which item 30419 or 50950 applies (Anaes.) | 817.10 |